X. L. Xu

Gene Expression Analyzed by High-resolution State Array Analysis and Quantitative Proteomics

Vivian L. MacKay, Xiaohong Li, Mark R. Flory et al. · Molecular & Cellular Proteomics · 2004 · 203 citations · Full text

Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.

X. L. Xu, Leeju C. Wu, Feng Du et al. · PubMed · 2001 · 104 citations

Pathology, Human Srbc, Cancer Biology +18

Phase 2a, randomized, double‐blind, placebo‐controlled, multicentre, parallel‐group study of an H₄R‐antagonist (<scp>JNJ</scp>‐39758979) in adults with uncontrolled asthma

Alexa P. Kollmeier, Andrew Greenspan, X. L. Xu et al. · Clinical & Experimental Allergy · 2018 · 16 citations

OP0308 Efficacy and safety results of guselkumab in patients with active psoriatic arthritis over 56 weeks from a phase 2a, randomised, double-blind, placebo-controlled study

Atul Deodhar, Alice B. Gottlieb, Wolf‐­Henning Boehncke et al. · Annals of the Rheumatic Diseases · 2018 · 14 citations · Full text

OP0054 EFFICACY OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF IL-23, ON ENDPOINTS RELATED TO AXIAL INVOLVEMENT IN PATIENTS WITH ACTIVE PSA WITH IMAGING-CONFIRMED SACROILIITIS: WEEK-24 RESULTS FROM TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES

Philip Helliwell, Dafna D. Gladman, Denis Poddubnyy et al. · Annals of the Rheumatic Diseases · 2020 · 14 citations · Full text